Pharmaceutical composition for treating insomnia

Abstract

The invention relates to a pharmaceutical composition for treating insomnia. Stephania sinica diels, spina date seed, polygala tenuifolia, nacre mother of pearl, acanthopanax root, schisandra chinensis and ligusticum wallichii are selected as materials; any common oral preparation is prepared according to a common preparation method of the modern preparation technology. The pharmaceutical composition disclosed by the invention has the effects of clearing away heat and calming the liver, and tranquilizing by nourishing the heart, can be used for improving insomnia and dreaminess, amnesia, dysphoria, dry and bitter mouth, headache and dizziness, palpitations and shortness of breath, and spontaneous sweating weakness, and is accurate in curative effect on insomnia caused by hot and suffocating liver and gall, and illness at ease, and significant in effect.

Description

【Technical field】

[0001] The invention relates to a pharmaceutical composition using plant Chinese herbal medicine as a raw material, in particular to a pharmaceutical composition for treating insomnia. 【Background technique】

[0002] Sleep disorders are now an epidemic. Insomnia is the most common sleep disorder problem. In recent years, the incidence of insomnia has been increasing year by year, and it has become one of the modern epidemics. WHO data shows that more than 30% of adults in the world suffer from insomnia, the incidence of insomnia in the United States is as high as 32% to 50%, in the United Kingdom 10% to 14%, in Japan 20%, and in France 30%. According to the latest sleep survey results released by the China Sleep Research Association, the prevalence of insomnia among adults in my country is as high as 57%, which is higher than the incidence of insomnia in developed countries abroad, and the number of insomniacs is increasing. More than 8 billion yuan. [0...

Images